The 
Clinical Pharmacogenetics Implementation Consortium (CPIC) was established in order to provide drug-dosing guidelines based on an individual’s genotype, if this genetic information is already available. These guidelines are published in 
Clinical Pharmacology and Therapeutics and summaries of the 
guidelines can be viewed in the PharmGKB on drug or gene pages.
Find out more about 
CPIC, and the 
CPIC gene-drug pairs.